As of 2025-07-04, the Intrinsic Value of ALX Oncology Holdings Inc (ALXO) is -12.16 USD. This ALXO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.45 USD, the upside of ALX Oncology Holdings Inc is -2,833.29%.
Based on its market price of 0.45 USD and our intrinsic valuation, ALX Oncology Holdings Inc (ALXO) is overvalued by 2,833.29%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -12.16 - -12.16 | -12.16 | -2,833.29% |
| P/E | (42.47) - (58.72) | (52.42) | -11880.5% |
| DDM - Stable | (20.04) - (84.74) | (52.39) | -11872.4% |
| DDM - Multi | (18.41) - (63.19) | (28.83) | -6578.8% |
| Market Cap (mil) | 23.78 |
| Beta | 1.66 |
| Outstanding shares (mil) | 53.44 |
| Enterprise Value (mil) | 15.17 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.54% |
| Cost of Debt | 5.00% |
| WACC | 7.84% |